Love Pharma Makes Canadian Stock Exchange Debut

These days, the term ‘alternative medicine’ is thrown around a lot. Whether it is major celebrities swearing by some sort of therapeutic tournament a la Gwyneth Paltrow or TikTokers showing alternative medicine tips, that sector is bigger than ever. Now, the popularity of alternative medicine is fueling a billion-dollar industry with all manner of products.

One of the latest victories for the sector comes from Love Pharma LUV, an alternative health company, which recently made its debut on the Canadian Stock Exchange (CSA). The company is also listed on the Frankfurt stock exchange, which is one of the biggest exchanges in the world. 

Love Pharma Goes Live

One of the reasons for this new success from Love Pharma is successful lines of psychedelic and cannabis-infused products. The market for both has grown tremendously over the years and Love Pharma has the right to produce and distribute patent-protected pharmaceutical products of that nature. The company claims that two of its lines thus far, “Bloom" and "Auraleaf", have been successes in the market and it is looking to add even more soon.

Another key to this success is Love Pharma's CEO Zachary Stadnyk, who has several profitable ventures under his belt. With this new company, he plans to take advantage of the "shroom boom”, the growth of the CBD and psychedelic products sector. In this vein, Love Pharma bought out BC-based Kick Pharmaceuticals, which then gave the company the right to produce 6 different products in North America.

One of the most important parts of the company’s process is clinical trials to ensure the effectiveness of each product. As Stadnyk puts it, Love Pharma isn’t just trying to cash in on a trend but wants to make sure that the market is flooded with quality products. One of its top products, Auraleaf, has been found to increase the effectiveness and speed of CBD performance by 30%.

Love Pharma to the World

While the North American CDB market is certainly huge, accounting for almost half of sales globally, Love Pharma is thinking beyond that single market. Currently, Love Pharma is making moves towards expanding to the rest of the world. This has included a partnership with Love Hemp, an international CBD manufacturer that distributes beyond North America.

Love Pharma will also be leveraging online channels such as eCommerce sites, MLM strategies, and traditional shops to move even more products. Speaking of products, Love Pharma is also developing new products to hit the market soon.

One of these is a biosynthetic psilocybin-infused strip to tap into the psychedelic market, which is believed to have a lot of potential. Lastly, Love Pharma is planning to release intimacy aid products in the future.

The growth of the CBD market has been remarkable in the last decade. Love Pharma believes it will continue to play a role in the industry well into the future.

The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. The content was purely for informational purposes only and not intended to be investing advice.